ESMO Breast Cancer 2019: Sponsor & Exhibitor Profiles

ESMO Breast Cancer 2019: Sponsor & Exhibitor Profiles

Who has already signed up?

ESMO gratefully acknowledge the valuable contribution the following organisations have made to the ESMO Breast Cancer 2019:

Platinum Sponsors

Daiichi Sankyo Cancer Enterprise


The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Learn more at


mylan logo

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. With a global portfolio pipeline of 20 biosimilar and insulin analog products across multiple therapy areas, our belief is that the world’s 7 billion people deserve access to high-quality, affordable medicine. We are dedicated to delivering better health by helping patients get the treatment they need.

Novartis Oncology


Novartis Oncology is a global leader in improving outcomes for patients. We seek to transform cancer care through distinctive scientific and clinical strategies focused on developing targeted, immuno-oncology and combination therapies to create more effective options for patients. For more information, please visit our website

Pfizer Oncology


At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of patients. Today, Pfizer Oncology has an industry-leading portfolio of 17 approved cancer medicines across more than 20 indications. Pfizer Oncology is striving to change the trajectory of cancer.

Gold Sponsors


Astra Zeneca Logo

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Eisai Co.


Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. Our human healthcare philosophy is “giving first thought to patients and their families and to increasing the benefits healthcare provides.” With over 10,000 employees globally, we strive to realise our philosophy by delivering innovative products in therapeutic areas including oncology and improving medicines access in developing countries.

F. Hoffmann - La Roche Ltd

Roche logo

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare–a strategy that aims to fit the right treatment to each patient in the best way possible. 



touchIME is the independent medical education division of Touch Medical Media specialised in creating cutting-edge, impactful and engaging IME and CME-accredited activities. From live events to innovative e-learning platforms, our programmes cover a wide range of therapeutic areas and are designed to support physicians, clinicians and related healthcare professionals in continuously developing their knowledge, effectiveness and productivity.

Silver Sponsors

Genomic Health International Sàrl

genomic health logo

Genomic Health is the world’s leading provider of genomic-based diagnostic tests that help optimize cancer care. The company applies its expertise and infrastructure to translate significant amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey. Genomic Health is based in Redwood City, California with international headquarters in Geneva, Switzerland. For more information, visit our website.


Lilly Oncology Logo

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.

MSD Sharp & Dohme

MSD logo 2018

For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases around the world.

Bronze Sponsors

Amgen (Europe) GmbH


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Abiotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential

Beacon Medicare Limited


BEACON Medicare Limited is a concern of BEACON Group and Global Marketing Partner of BEACON Oncology Limited. BEACON is the No-1 Oncology company and one of the leading pharma companies of Bangladesh. BEACON manufactures more than 150 life saving anti-cancer products which includes conventional chemotherapy, Monoclonal antibodies, Targeted therapies, Nano and Lyposomal preparations. After meeting the local demand, BEACON exports its medicines globally.

NanoString Technologies


NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 2,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.


philips logo

Philips OncoSignal Molecular Pathway Diagnostics quantifies the activity of the signal transductionpathways that drive tumor growth, having the potential to offer actionable therapy responseprediction for informed personalized cancer treatment decisions. This is achieved by measuring mRNAtranscribed from target genes ofthe pathway transcription factors, and data interpretation withcomputational pathway models.

Seattle Genetics

seattle genetics logo

Seattle Genetics, an innovative international biotechnology company, develops and commercialises antibody-based therapies for cancer. Our industry-leading antibody-drug conjugates harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. We have a robust pipeline designed to address unmet needs and improve outcomes for patients. Seattle Genetics is headquartered in the US, with European and International operations in Switzerland.

Educational Grant



One of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit